Lenz
San Diego, US · 8 known investors
Find your way into Lenz
379 people in our graph share verified history with the Lenz team — schools, employers, funds. One of them is your warm intro.
Tony Conradunlockedknows Eef Schimmelpennink · together at Numico (overlapped)
×3knows the team · via Queensland University of Technology
×3knows the team · via Numico
×4knows the team · via Pfizer
knows the team · via Wageningen University & Research
LENZ Therapeutics is a pharmaceutical company developing and commercializing VIZZ™, an FDA-approved aceclidine-based eye drop for treating presbyopia, a vision condition affecting over 128 million people in the US. The company is focused on providing a once-daily pharmaceutical solution to restore near vision across a broad patient population aged 45 and above.
Founders & leadership
JM
James McCollumCo-founder, Board Member
ES
Eef SchimmelpenninkinPresident and CEOCEO of LENZ Therapeutics, a pharmaceutical company commercializing an FDA-approved eye drop for presbyopia. Schimmelpennink has over 20 years of experience in biopharmaceutical R&D, commercial operations, finance, business development, and manufacturing.
ES
Evert SchimmelpenninkPresident and CEO
Investors · 8
Alpha Wave GlobalMiami
RA CapitalBoston
Raptor GroupMiami Beachvia James J. Pallotta · inferred
RTW Investments L.P.reportedNew York
Sectoral Asset ManagementreportedMontreal
Versant VenturesreportedSan Francisco · $250K – $5M
Also in the syndicate · 2
Alpha Wave VenturesPoint 72
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMar 2023
Sectoral Asset Management (lead), Alpha Wave Ventures, Point 72, RA Capital Management, RTW Investments, Versant Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Lenz do?
- LENZ Therapeutics is a pharmaceutical company developing and commercializing VIZZ™, an FDA-approved aceclidine-based eye drop for treating presbyopia, a vision condition affecting over 128 million people in the US. The company is focused on providing a once-daily pharmaceutical solution to restore near vision across a broad patient population aged 45 and above.
- Who founded Lenz?
- Lenz was founded by James McCollum.
- Who are Lenz's investors?
- Lenz's investors include Alpha Wave Global, RA Capital, Raptor Group, RTW Investments L.P., Sectoral Asset Management, Versant Ventures.
- Where is Lenz headquartered?
- Lenz is headquartered in San Diego, US.